Who is sponsoring NCT05293392?

NCT05293392 is sponsored by Nemours Children's Health System.

What drugs are being tested in NCT05293392?

Interventions in NCT05293392: Culturally-Tailored COVID-19 Vaccine Uptake Intervention, Standard Care.

Is NCT05293392 still recruiting?

NCT05293392 is currently completed. Last updated 28 September 2023.

Are results published for NCT05293392?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-09-28 · How we verify

NCT05293392

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving COVID-19 Vaccine Uptake Among Black and Latino Youth

Completed NA Results posted Last updated 28 September 2023

What this trial tests

NA trial testing Culturally-Tailored COVID-19 Vaccine Uptake Intervention in COVID-19 in 5,792 participants. Completed in 20 May 2022.

Timeline

31 January 2022

Primary endpoint
20 May 2022

20 May 2022

Quick facts

Lead sponsor	Nemours Children's Health System
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	5,792
Start date	31 January 2022
Primary completion	20 May 2022
Estimated completion	20 May 2022
Sites	1 location across United States

Drugs / interventions tested

Culturally-Tailored COVID-19 Vaccine Uptake Intervention
Standard Care — full drug profile →

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

Nemours Children's Health System

Who can join

Eligibility, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

COVID-19 Vaccination Rate for Eligible Children Primary · 4 months

Percent of patients who received a COVID-19 vaccine among all children who were eligible for and had not yet been vaccinated for the COVID-19 vaccine during the time of their visit to one of the four participating primary care clinics.

Phase 1: Community-Tailored Handouts

Group	Value	95% CI
Culturally-Tailored COVID-19 Vaccine Uptake Intervention	21.3
Standard Care	33.5

Phase 2: Videos Featuring Local Families

Group	Value	95% CI
Culturally-Tailored COVID-19 Vaccine Uptake Intervention	16.4
Standard Care	26.7

Phase 3: Family-Centered Communication at Primary Care Clinic

Group	Value	95% CI
Culturally-Tailored COVID-19 Vaccine Uptake Intervention	21.9
Standard Care	19.4

Phase 4: Community Health Worker Outreach

Group	Value	95% CI
Culturally-Tailored COVID-19 Vaccine Uptake Intervention	14.4
Standard Care	10.6

Sponsor's own description

Black and Latino youth may be less likely to get the COVID-19 vaccine than White youth. In this study we will work with community members to come up with ways to help Black and Latino families learn more about the COVID-19 vaccine and get the COVID-19 vaccine. We will test these ideas out in pediatric primary care clinics. This study will help us make sure that all youth have an equal chance of getting the COVID-19 vaccine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Nemours Children's Health System trials

Trials by the same sponsor.

NCT05936385 — Mobile Integrated Care for Childhood Obesity · NA · completed
NCT03796221 — Parenting Intervention for Pediatric Obesity · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05293392 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nemours Children's Health System
Last refreshed: 28 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05293392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing